Study of licarbazepine in the treatment of manic episodes of bipolar disorder.
Phase of Trial: Phase III
Latest Information Update: 28 Mar 2017
At a glance
- Drugs Licarbazepine (Primary)
- Indications Bipolar I disorders
- Focus Registrational; Therapeutic Use
- Sponsors Novartis; Novartis Pharmaceuticals
- 13 Nov 2007 Status change from recruiting to completed.
- 29 Nov 2005 New trial record.